ArticleOpen forum infectious diseases2023

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.

Selin Somersan-Karakaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.